Micro Medical Pulmolife

Micro Medical PulmoLife COPD Screening Device - FEV1 & Lung Age (PL10)

PulmoLife is a new COPD screening device, designed for quick and easy screening of adult smokers for early detection of COPD. Smokers are at the greatest risk of developing COPD and decline in lung function in susceptible smokers has been shown to be twice that of non-smokers.

This small, innovative device measures Forced Expiratory Volume (FEV1), the measurement of choice in COPD screening. The unit will display a patient’s result together with the FEV1 as a percentage of their predicted value. These results are used to calculate a ‘Lung Age’. The associated ‘Lung Age’ graphical display may help the patient realise the physical damage caused by smoking, encouraging attendance for smoking cessation advice and full spirometry assessment, leading to early diagnosis and appropriate management of COPD.

Features and Benefits

• Measures FEV1 within the first second of expiration
• Gives FEV1 as a percentage of predicted values (FEV1%) indicating the likelihood and severity of COPD
• 'Lung Age'  Interpretation (Morris and Temple) demonstrates to smokers the damage caused by smoking in a way they can understand
• Useful as a motivational tool for smoking cessation
  
• Suitable for:
  
  • FEV1 testing programs
  • Identification of early signs of COPD in smokers over 40 or anyone with symptoms
  • Helping susceptible smokers to quit

Specifications

- Formerly manufactured by MicroMedical, which is now Carefusion